Biotech Values

[poorgradstudent]

While I basically agree with you, ONXX trying to prove you wrong:

I think this might be a case where we'll see if the FDA cares about accelerated approval anymore. The company is following the Velcade path almost step by step, have shown reasonable efficacy, reasonable safety, and two phase 3 trials are underway.

I'm not holding my breath, but I think that the case for accelerated approval here is relatively strong.